Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
| Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study (Bone Marrow Transplantation, (2019), 54, 3, (465-468), 10.1038/s41409-018-0294-2) | 2020 |
|
Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
| High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study | 2019 |
|
Dr Anne Lennard
| Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial | 2018 |
|
Joseph O'Donoghue
Dr Anne Lennard
| Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent | 2017 |
|
Dr Anne Lennard
| Outcomes with rituximab monotherapy versus r-chop in post-transplant lymphoproliferative disease arising after solid organ transplant: a United Kingdom multicentre study | 2016 |
|
Dr Michal Sieniawski
Dr Anne Lennard
| A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma | 2015 |
|
Dr Anne Lennard
Dr Viney Wadehra
| Anaplastic large cell lymphoma in a reconstructed breast using a silicone implant: A UK case report | 2014 |
|
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
| Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients | 2014 |
|
Dr Michal Sieniawski
Dr Anne Lennard
| Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies | 2011 |
|
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
| Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation | 2010 |
|
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al. | The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control | 2010 |
|
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
| Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens | 2009 |
|
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Dr Anne Lennard
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al. | Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group. | 2008 |
|
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
| Sequential Evaluation of Outcome in Enteropathy Associated T Cell Lymphoma Comparing Standard Therapeutic Approaches - Surgery or CHOP-Like Chemotherapy with a New High Dose Ifosfamide/Methotrexate and Autologous Stem Cell Transplant Regimen: A Prospective Study of Scotland and Newcastle Lymphoma Group | 2008 |
|
Dr Michal Sieniawski
Dr Tryfonia Mainou-Fowler
Dr Jennifer Wilkinson
Dr John Davison
Professor Graham Jackson
et al. | The effect of Diffuse Large B-Cell Lymphoma (DLBCL) treatment regimens on survival: a prospective cohort study [Poster] | 2008 |
|
